SCHEMBL4740110

SCHEMBL4740110

COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)C2)[nH]c1=N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 11/20 0.61
CDK4 P11802 11/20 0.61
CCND1 P24385 11/20 0.61
CDK2 P24941 11/20 0.61
CDK9 P50750 5/20 0.61
CASK O14936 1/20 0.61
ROCK2 O75116 1/20 0.61
CDKL5 O76039 1/20 0.61
STK10 O94804 1/20 0.61
CDK14 O94921 1/20 0.61
ABL1 P00519 1/20 0.61
EGFR P00533 1/20 0.61
MAK P20794 1/20 0.61
CDK11B P21127 1/20 0.61
TTK P33981 1/20 0.61
CLK1 P49759 1/20 0.61
CLK2 P49760 1/20 0.61
CLK3 P49761 1/20 0.61
GSK3A P49840 1/20 0.61
GSK3B P49841 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4739832 0.83 CDK1 (0.52) CDK1CDK4CCND1CDK2CDK9
SCHEMBL3522526 0.81 CDK1 (0.91) CDK1CDK4CCND1CDK2CDK9
SCHEMBL4730769 0.81 CDK1 (0.67) CDK1CDK4CCND1CDK2CDK9
SCHEMBL4730130 0.80 CDK2 (0.64) CDK1CDK4CCND1CDK2CDK9
SCHEMBL4739451 0.76 CDK2 (0.49) CDK1CDK4CCND1CDK2CDK9
Rg-547 SCHEMBL2397067 0.76 CDK1 (1.00) CDK1CDK4CCND1CDK2CDK9
Rg-547 SCHEMBL29644949 0.76 CDK1 (1.00) CDK1CDK4CCND1CDK2CDK9
SCHEMBL3522420 0.75 CDK1 (0.77) CDK1CDK4CCND1CDK2CDK9
SCHEMBL4348141 0.74 CDK1 (0.84) CDK1CDK4CCND1CDK2CDK9
SCHEMBL4740788 0.74 CDK2 (0.47) CDK1CDK4CCND1CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957466-A1 4-AMINOPYRIMIDINE-5-THIONE-DERIVATIVES FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2008-08-20 EP disclosed
WO-2007060110-A1 4-AMINOPYRIMIDINE-5-THIONE-DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2007-05-31 WO disclosed